SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-078682
Filing Date
2024-06-27
Accepted
2024-06-27 19:01:24
Documents
2
Period of Report
2024-06-27

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1564
2 EX-24.1 ck0001768446-ex24_1.htm EX-24.1 18535
  Complete submission text file 0000950170-24-078682.txt   21552
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Issuer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2525 SMITH STREET SCOTCH PLAINS NJ 07076
Business Address
Thomas Stephen Basil (Reporting) CIK: 0002027962 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40708 | Film No.: 241080863